The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Diversity, equity, and inclusion (DEI) and health equity (HE) education in hematology/oncology (HO) fellowship: A longitudinal curriculum.
 
Norin Ansari
No Relationships to Disclose
 
Kristina Fanucci
No Relationships to Disclose
 
Barbara Burtness
Consulting or Advisory Role - Abbvie; ALX Oncology; Arvinas; Coherus Biosciences; CUE Biopharma; Genentech/Roche; IO Biotech; Kura Oncology; Macrogenics; Merck; Merck KGaA; Vaccinex
Speakers' Bureau - Clinical Education Alliance; Oncology Education
Research Funding - CUE Biopharma (Inst); Exelixis (Inst); Merck; Merck (Inst)
 
Sarah B. Goldberg
Honoraria - Amgen
Consulting or Advisory Role - AstraZeneca/MedImmune; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Genentech/Roche; Genzyme; Janssen; Merck; Mirati Therapeutics; Regeneron; Summit Therapeutics; Takeda
Research Funding - Amgen (Inst); AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Mirati Therapeutics; Pfizer (Inst); Spectrum Pharmaceuticals (Inst)
 
Michael E. Hurwitz
Employment - Arvinas (I); Gamida Cell (I); Pfizer (I)
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; crispr therapeutics; Exelixis; Janssen; Nektar; pliant
Research Funding - Achilles Therapeutics; Apexigen; Astellas Pharma; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Corvus Pharmaceuticals; Endocyte; Endocyte; Genentech; Genmab; Innocrin Pharma; Iovance Biotherapeutics; Lilly; Merck; Nektar; Novartis; Novartis; Pfizer; Progenics; Sanofi/Aventis; Seagen; Torque; Unum Therapeutics
 
Nikolai Alexandrovich Podoltsev
Consulting or Advisory Role - Abbvie; Blueprint Medicines; Constellation Pharmaceuticals; CTI BioPharma Corp; Incyte; Novartis; Pharmaessentia
Research Funding - AI Therapeutics (Inst); Arog (Inst); Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); CTI BioPharma Corp (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Jazz Pharmaceuticals (Inst); Kartos Therapeutics (Inst); Pfizer (Inst); Samus Therapeutics (Inst); Sunesis Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Incyte
Other Relationship - Syneos Health
 
Alfred Ian Lee
No Relationships to Disclose
 
Pamela L. Kunz
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Amgen; Crinetics Pharmaceuticals; Genentech/Roche; HUTCHMED; Ipsen; ITM Isotope Technologies Munich; Natera
Research Funding - Advanced Accelerator Applications/Novartis (Inst)